您的位置: 首页 > 农业专利 > 详情页

CAPSULE FORMULATION COMPRISING MONTELUKAST AND LEVOCETIRIZINE
专利权人:
HANMI PHARM. CO.; LTD.
发明人:
Yong II KIM,Dong Ho KIM,Taek Kwan KWON,Kyeong Soo KIM,Jae Hyun PARK,Jong Soo WOO
申请号:
US14934348
公开号:
US20160089339A1
申请日:
2015.11.06
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Disclosed is a capsule formulation for preventing or treating allergic rhinitis and asthma, which comprises two separate layers of: (1) a Montelukast layer comprising montelukast or a pharmaceutically acceptable salt thereof; and (2) a Levocetirizine layer comprising levocetirizine or a pharmaceutically acceptable salt thereof; and a method for the preparation thereof. The capsule formulation according to the present invention can completely separate two active ingredients, thereby minimizing the reactivity between them and improving product stability against aging effects, and thus, can optimize the therapeutic effects.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充